^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    multi-CAR-T cell therapy

    i
    Other names: multi-CAR-T cell therapy, 4SCAR19 and 4SCAR20/22/70/PSMA/13/79b/GD2
    Associations

    News

    Trials
    Company:
    SZGIMI
    Drug class:
    CD19-targeted CAR-T immunotherapy, CD20-targeted CAR-T immunotherapy, CD70-targeted CAR-T immunotherapy, CD22-targeted CAR-T immunotherapy, PSMA-targeted CAR-T immunotherapy, CD13-targeted CAR-T immunotherapy, CD79b-targeted CAR-T immunotherapy, GD2-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over4years
    Multi-CAR-T Cells Targeting B Cell Lymphomas (clinicaltrials.gov)
    P1/2, N=11, Recruiting, Shenzhen Geno-Immune Medical Institute
    New P1/2 trial • CAR T-Cell Therapy
    |
    CD19 (CD19 Molecule) • CD79B (CD79b Molecule) • CD22 (CD22 Molecule) • CD70 (CD70 Molecule)
    |
    CD19 expression
    |
    multi-CAR-T cell therapy